Latest Posts

All Posts

Synthetic promoter AAVs for cell-type specific expression in retinal cells

Posted by Beth Kenkel on Mar 12, 2020 9:15:00 AM

Adeno-associated virus (AAV) is a popular tool for gene delivery, but it has a drawback: how do you ensure your gene goes where you want it to? Knowing that a gene is expressed in a particular cell type is important not only for translational research, such as gene therapy, but also basic research. To improve cell-type specificity of AAV, work has focused on modifying the outside protein shell, or capsid, of the virus so that it only enters and delivers it cargo to certain cell types. 

Read More >

Topics: Viral Vectors, Cell Tracing, AAV

Droplet Digital PCR for AAV Quantitation

Posted by Kate Harten DeMaio on Jan 16, 2020 9:18:58 AM

Since Addgene began producing AAV vector preparations, we have used quantitative PCR to evaluate the physical titer of our preps. We often repeat this assay to confirm that our results are accurate. But what if we could repeat this assay 10,000 times to ensure that our titers were as accurate as possible? This is where droplet digital PCR (ddPCR) comes in.

Read More >

Topics: Viral Vectors, Viral Vector Protocols and Tips, AAV

Three Key Considerations For Precise Neuronal Targeting Using AAV Technologies

Posted by Susanna Bachle on Nov 27, 2019 9:03:45 AM

Understanding the biology behind brain development, learning, and behavior poses many challenges in neuroscience with many brain regions, neuronal networks, and specific neuronal populations to consider. To tease apart how different neurons impact a certain output, neuroscientists have begun to use more precise genetic tools: activators, inhibitors, sensors, recombinases, and more. With the help of adeno-associated viral vectors (AAV), neuroscientists can combine classical genetic tools with the manipulation of specific neuronal subtypes and determine how these changes affect the phenotype. Viral vectors and genetic approaches are continuously refined and developed so there are many combinations to choose from for your experiments!

Read More >

Topics: Viral Vectors, Viral Vector Protocols and Tips, AAV

Beyond the Blood Brain Barrier: PHP.B Enters the Central Nervous System Via the LY6A Receptor

Posted by Beth Kenkel on Jul 23, 2019 8:46:19 AM

One of the biggest barriers to gene therapy treatment of central nervous system (CNS) diseases is the blood brain barrier (BBB). It’s the BBB’s job to block the entry of pathogens to the CNS, but this also stops viral vectors, such as adeno-associated virus (AAV), from reaching their targets.

Read More >

Topics: Viral Vectors, AAV

Addgene Protocols Go Viral: AAV Purification and Titration

Posted by Eddy Page on Jun 13, 2019 8:19:13 AM

Since rolling out our viral service in 2016, Addgene has shipped thousands of AAV and lentiviral preps to scientists around the world. In the years since, our scientists have optimized many steps in the viral production and quality control process to improve both the yield and quality of the viral preps. For example, last year we published an article describing a sucrose supplementation strategy to improve yield. In addition, as described in this blog post, the team developed a viral genome sequencing strategy to confirm the identity and purity of all AAV viral lots.

Read More >

Topics: Viral Vectors, Viral Vector Protocols and Tips, AAV

Click here to subscribe to the Addgene Blog
 
Subscribe

 

All Topics

see all

Recent Posts